References
- Tshesche H, Mair G, Godec G, et al. The primary structure of porcine glandular kallikreins. International symposium on kinins, Tokyo 1978. Adv Exp Med Biol 1979; 120A-B: 245–60
- Bhoola K D., May May Yi R, Morley J, Schachter M. Release of kinin by an enzyme in the accessory sex glands of the guinea-pig. J Physiol 1962; 163: 269–80
- Seidel G. Two functionally different kininogens in human plasma. Agents Actions 1973; 3: 12–19
- Sumi H, Takasugi S, Toki N. Studies on kalli-krein-kinin system in plasma of patients with acute pancreatitis. Clin Chim Acta 1978; 87: 113–8
- Takasugi S, Toki N. Studies on a kallikrein-kinin system in plasma of patients with acute pancreatitis: The preparation and characterization of a kallikrein-like enzyme in patient's plasma. Clin Biochem 1980; 13: 156–9
- Koh H, Schramm H J. Isolation of alpha2-macro-globulin-glandular kallikrein complex from human plasma. International Conference on Kinin ‘91 Munich. “Towards understanding the molecular basis of kinin action” Abstract Volume, H Fritz, W Müller-Esterl, M Jochum, A Roscher, K Luppertz. 1991; 254
- Vahtera E, Hamberg U. Absence of binding of pancreatic and urinary kallikreins to alpha2-macro-globulin. Biochem J 1976; 157: 521–4
- Takasugi S, Toki N, Sasaki K, Sumi H. Purification and characterization of kallikrein from plasma of patients with acute pancreatitis: Effects of trypsin on interaction between alpha2-macro-globulin and pancreatic kallikrein. Agents Actions (Suppl.) 1982; 9: 126–30
- Geiger R, Stuckstedte U, Clausnitzer B, Fritz H. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha j-antitrypsin (alpha1-protease inhibitor). Hoppe-Seyler's Z Physiol Chem 1981; 362: 317–25
- Hirano K, Okumura Y, Hayakawa S, Adachi T, Sugiura M. Inhibition of human tissue kallikrein by alpha,-proteinase inhibitor. Hoppe-Seyler's Z Physiol Chem 1984; 365: 27–32
- Johansson B G. Agarose gel electrophoresis. Scand J Clin Lab Invest 1972; 29(Suppl. 24)7–19
- Ganrot P O. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29(Suppl. 124)39–41
- Laurell C B. Electroimmunoassay. Scand J Clin Lab Invest. 1972; 29(Suppl. 124)21–37
- Amundsen E, Putter J, Friberger P, Knos M, Lars-braten M, Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol 1979; 120A: 83–95
- Blackberg M, Ohlsson K. Studies on the release of tissue kallikrein in experimental pancreatitis in the pig. Eur Surg Res 1994; 26: 116–24
- Thorell J I., Johansson B G. Enzymatic iodination of polypeptides with 125I to high specific activity. Bio-chim Biophys Acta 1971; 251: 363–9
- Diniz C R., Carvalho I F. A micromethod for determination of bradykininogen under several conditions. Ann NY Acad Sci 1963; 104: 77–89
- Bieth J G. In vivo significance of kinetic constants of macromolecular proteinase inhibitors. Adv Exp Med Biol 1984; 167: 97–109
- Christensson A, Laurell C-B, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755–63
- Zuber M, Sache E. Isolation and characterization of porcine pancreatic kallikrein. Biochemistry. 1974; 13: 3098–110
- Hojima Y, Matsuda Y, Moriwaki C, Moriya H. Homogeneity and multiplicity forms of glandular kallikrein. Chem Pharm Bull 1975; 23: 1120–7
- Bieth J, Aubry M, Travis J. The interaction of human cationic trypsin and chymotrypsin II with human serum inhibitors. Bayer-Symposium V Proteinase Inhibitors, H Fritz, H Tschesche, L J. Greene. Springer-Verlag, Berlin 1974; 53–62
- Borgström A, Ohlsson K. Radioimmunological determination and characterization of cathodal tryp-sin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest 1976; 36: 809–14
- Rabito S F., Scicli A G., Kher V, Carretero O A. Immunoreactive glandular kallikrein in rat plasma: a radioimmunoassay for its determination. Am J Physiol. 1982; 242: H602–H610
- Ohlsson K. Elimination of 125I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dog. Acta Physiol Scand 1971; 81: 269–72
- Borges D R., Kouyoumdjian M, Prado E S., Prado J L. Receptor-mediated clearance of tissue kallikrein by rat liver. Adv Exp Med Biol. 1986; 198A: 235–9
- Ohlsson K, Laurell C B. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med 1976; 51: 87–92
- Rabito S, Seto M, Maitra S R., Carretero O A. Clearance and metabolism of glandular kallikrein in the rat. Am J Physiol 1985; 248: E664–E668
- Xiong W, Tang C Q., Zhou G X., Chao L, Chao J. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein. J Lab Clin Med. 1992; 119: 514–21
- Chao J, Tillman D M., Wang M, Margolius H S., Chao L. Identification of a new tissue-kallikrein-binding protein. Biochem J 1986; 239: 325–31
- Ecke S, Geiger M, Resch I, Jerabek I, Stingl L, Maier M, Binder B R. Inhibition of tissue kallikrein by Protein C inhibitor. J Biol Chem 1992; 267: 7048–52